Clinical and biochemical phenotypes, genotypes, and long-term outcomes of individuals with galactosemia type I from a single metabolic genetics center in Alberta. [PDF]
Almenabawy N +6 more
europepmc +1 more source
Current Status of Newborn Screening in Southeastern and Central Europe. [PDF]
Požun N +44 more
europepmc +1 more source
Odimet®: A Pioneering Tele-Health Tool to Empower Dietary Treatment and the Acute Management of Inborn Errors of Metabolism-An Assessment of Its Effectiveness during the COVID Pandemic. [PDF]
Sánchez-Pintos P +3 more
europepmc +1 more source
Clinical and Developmental Outcomes After 50 Years of Newborn Bloodspot Screening for Classical Galactosaemia in the Republic of Ireland. [PDF]
Pereira D +18 more
europepmc +1 more source
Newborn Screening in Developing Countries: The Need of the Hour. [PDF]
Gaikwad S, Ganvir S, Uke P.
europepmc +1 more source
Case-Based Learning in Clinical Biochemistry: Performance and Perception of MBBS Phase-I Students in Chhindwara Institute of Medical Sciences, Chhindwara, Madhya Pradesh, India. [PDF]
Raghuwanshi K +5 more
europepmc +1 more source
Changes in Child Behaviour Following a Brief Parenting Intervention (Triple P) for Families of Children with Phenylketonuria (PKU): A Case Series. [PDF]
Kirby G +5 more
europepmc +1 more source
Metabolic Liver Diseases Presenting as Pediatric Onset Hypoglycemia: A Hepatologist's Primer. [PDF]
Verma S +4 more
europepmc +1 more source
Identification of novel mutations in classical galactosemia [PDF]
Classical galactosemia is an autosomal recessive disorder of galactose metabolism due to galactose-1-phosphate uridyltransferase (GALT) deficiency. Treatment through restriction of dietary galactose intake is lifesaving, but, in spite of this diet, most patients develop abnormalities.
Annet Bosch +2 more
exaly +3 more sources

